Advarra Acquires Longboat


Advarra today announced the acquisition of Longboat, a provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement. The addition of Longboat, headquartered in Dublin, Ireland, enables Advarra to offer a broader suite of technology solutions to sites, biopharmaceutical companies, and clinical research organizations (CROs) globally, through a site-centric approach, driving increased efficiencies and compliance in clinical trials.

Longboat’s integrated platform helps to simplify trial conduct and participation, increase study compliance, and accelerate clinical trials. Longboat provides study teams with comprehensive oversight of and engagement with sites globally, enabling swift action to keep studies on track. Longboat also gives site staff the tools they need to focus on patient care while maintaining protocol compliance.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.